Mirum Targets $500m Sales For Just-Approved Rare Liver Disorder Drug

FDA Green Light For Alagille Syndrome Therapy Livmarli

 
• By Kevin Grogan
false start
Mirum quick out of the blocks with Livmarli launch

More from New Products

More from Scrip